ReviewHealthcare management forum2016
Universal prescription drug coverage in Canada: Long-promised yet undelivered.
Review in Healthcare management forum, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Exploring the experiences of people in Ontario, Canada who have trouble affording medicines: a qualitative concept mapping study.BMJ open · 2019Trial
- Predictors of cost-related medication nonadherence in Canada: a repeated cross-sectional analysis of the Canadian Community Health Survey.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2024Article
- The Intersectional Impact of Cost-Related Non-Adherence and Depression: A Cross-Sectional Analysis of the Canadian Community Health Survey by Sex, Race, and Indigeneity.Community mental health journal · 2024Article
- Predictive risk modelling of high resource users under different prescription drug coverage policies in Ontario and Manitoba, Canada.BMC health services research · 2023Article
- Exploring Biologic Treatment Hesitancy Among Black and Indigenous Populations in Canada: a Review.Journal of racial and ethnic health disparities · 2023Review
- The impact of prescription drug insurance on cost related non-adherence to medications in Canada: A Heckman sample selection approach.PloS one · 2023Article
- Development and validation of a social vulnerabilities survey for medical inpatients.BMJ open · 2022Article
- Underuse of cardiorenal protective agents in high-risk diabetes patients in primary care: a cross-sectional study.BMC primary care · 2022Article
- Quality of rheumatology care for patients with fibromyalgia and chronic pain syndromes.BMJ open quality · 2021Article
- The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.Journal of infection and public health · 2021Review
- Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.International journal of health policy and management · 2020Article
- It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.International journal of health policy and management · 2020Article
- Contrasting current challenges from the Brazilian and Canadian national health systems: The Besrour Papers: a series on the state of family medicine in Canada and Brazil.Canadian family physician Medecin de famille canadien · 2019Review
- UHC2030's Contributions to Global Health Governance that Advance the Right to Health Care: A Preliminary Assessment.Health and human rights · 2019Article
- Economic barriers, evidentiary gaps, and ethical conundrums: a qualitative study of physicians' challenges recommending HPV vaccination to older gay, bisexual, and other men who have sex with men.International journal for equity in health · 2019Article
- Acceptability and feasibility of a national essential medicines list in Canada: a qualitative study of perceptions of decision-makers and policy stakeholders.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019Article
- Inter- and intraprovincial inequities in public coverage of cancer drug programs across Canada: a plea for the establishment of a pan-Canadian pharmacare program.Current oncology (Toronto, Ont.) · 2019Article
- Wait lists and adult general surgery: is there a socioeconomic dimension in Canada?BMC health services research · 2019Article
- Cost-related nonadherence to prescription medications in Canada: a scoping review.Patient preference and adherence · 2018Article
- Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.Journal of pharmaceutical policy and practice · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Canada's universal public healthcare system is unique among developed countries insofar as it does not include universal coverage of prescription drugs. Universal, public coverage of prescription drugs has been recommended by major national commissions in Canada dating back to the 1960s. It has not, however, been implemented. In this article, we extend research on the failure of early proposals for universal drug coverage in Canada to explain failures of calls for reform over the past 20 years. We describe the confluence of barriers to reform stemming from Canadian policy institutions, ideas held by federal policy-makers, and electoral incentives for necessary reforms. Though universal "pharmacare" is once again on the policy agenda in Canada, arguably at higher levels of policy discourse than ever before, the frequently recommended option of universal, public coverage of prescription drugs remains unlikely to be implemented without political leadership necessary to overcome these policy barriers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.